Denmark· DK-28101339488
Mianserin "Viatris"
A mianserin product containing mianserinhydrochlorid, registered in Denmark by Viatris Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Mianserin is registered in 15 of 19 countries.
Countries holding a registration under ATC N06AX03 (mianserin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Mianserin · ATC N06AX03
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mianserin costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.32 in France to $1.15 in Switzerland — a ×3.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mianserin · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.15
- IT Italy$0.68
- FR France$0.32
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- MIANSERINHYDROCHLORID
- Manufacturer
- Viatris Limited
- Country
- Denmark (DK)
- ATC code
- N06AX03
- ATC class
- Mianserin
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101339488
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for mianserin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mianserin · interactions on record
19 records
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06AX03
Mianserin, as other registers publish it.
- PolandDeprexoletAdamed Pharma S.A.
- PolandDeprexoletAdamed Pharma S.A.
- PolandDeprexoletAdamed Pharma S.A.
- ItalyLANTANON*30 cpr rivestite 30 mgORGANON ITALIA Srl
- PolandLerivonOrganon Polska Sp. z o.o.
- PolandLerivonOrganon Polska Sp. z o.o.
- CzechiaLERIVONMerck Sharp & Dohme B.V., Haarlem
- CzechiaLERIVONN.V. Organon, Oss
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dff0d5d7-53b5-4d30-93fa-fda04fa77476 GET /v1/drugs/dff0d5d7-53b5-4d30-93fa-fda04fa77476?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "10 mg",
"auth_role": "DKMA",
"dk_drugid": "28101339488",
"substance": "MIANSERINHYDROCHLORID",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "32633"
}See everything about mianserin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.